Ethyl 2-(2-(4,5-Bis(4-Methoxyphenyl)Thiazol-2-Yl)-1H-Pyrrol-1-Yl)Acetate

Pamicogrel is primarily investigated for its applications in cardiovascular medicine, particularly in preventing thrombotic events associated with atherosclerosis and other vascular disorders. Its anti-platelet properties make it a candidate for treating conditions where platelet aggregation poses a risk, such as coronary artery disease. Ongoing research aims to explore its efficacy in broader therapeutic contexts, including inflammatory diseases.

Pamicogrel exhibits significant biological activity as an anti-platelet agent. In vitro studies have demonstrated that it effectively inhibits neutrophil migration and calcium influx induced by leukotriene B4 in animal models. This activity is critical in managing inflammatory responses and preventing excessive clot formation. Furthermore, Pamicogrel's role in modulating cyclooxygenase pathways contributes to its therapeutic potential in cardiovascular diseases.

Please email your required order quantity and detailed technical specifications to sales@.
Our sales team will promptly prepare an accurate quotation for your bulk order and provide a comprehensive pricing proposal.

All products are for research and development use only, not for any other uses, and must be handled by technically-qualified persons.

These products are explicitly not intended to be used in foods and/or cosmetics and/or drugs (human and veterinary) and/or consumer products and/or biocides and/or pesticides of any kind unless explicitly stated otherwise.

Products are not sold to individuals. We do not ship to residential addresses. Consumer orders will be cancelled without notice.

New customers undergo an internal onboarding process. As part of this process, new customers may be asked for more information. Additional restrictions may apply.